Pacira's pain drug Exparel, which uses bupivacaine, a local analgesic, received approval from the FDA, a Reuter's report said.
The drug is delivered through using the company's DepoFoam technology and extends the duration of the analgesia. In clinical trials, the drug provided pain relief for up to 72 hours compared with the analgesic's normal time of less than seven hours.
Related Articles on Pain Management:
Study: Lower Dose of Corticosteroids Just as Effective as Higher for Shoulder Pain
Pain Makes Patients More Self-Absorbed
Nanoparticles May Improve Arthritis Pain Treatment
The drug is delivered through using the company's DepoFoam technology and extends the duration of the analgesia. In clinical trials, the drug provided pain relief for up to 72 hours compared with the analgesic's normal time of less than seven hours.
Related Articles on Pain Management:
Study: Lower Dose of Corticosteroids Just as Effective as Higher for Shoulder Pain
Pain Makes Patients More Self-Absorbed
Nanoparticles May Improve Arthritis Pain Treatment